Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
[3H]A317491 | 5407 | [3H]A 317491, [3H]A-317491 | |||||||
[3H]A-585539 | 3974 | ||||||||
[3H]A778317 | 4076 | ||||||||
[3H]A804598 | 5408 | [3H]A 804598 | |||||||
[3H]A81988 | 3938 | [3H]-A81988 | |||||||
[125I]AB-MECA | 436 | [125I]-AB-MECA, [125I]5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide, [125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide | |||||||
[125I]ABOPX | 452 | [125I]3-(3,4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine | |||||||
Ac-[13C,15N]PGP | 12599 | ||||||||
[3H]acetylcholine | 8593 | ||||||||
[14C]acetylCoA | 4541 | [14C]-acetylCoA | |||||||
[125I][Ac-His1]PACAP-27 | 2260 | [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||||
[35S]ACPPB | 4584 | [35S]-ACPPB | |||||||
[125I]ACTH-(1-24) | 3767 | [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24) | |||||||
[3H]AD5075 | 2702 | [3H]-AD5075 | |||||||
[35S]ADPβS | 3408 | ||||||||
[3H]AF DX-384 | 368 | [3H]AF-DX 384 | |||||||
[125I][Ala1,3,11,15]ET-1 | 3760 | [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1 | |||||||
β-Ala-Lys-AMCA | 9501 | β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA | |||||||
[14C]alanine | 4542 | [14C]-alanine | |||||||
[3H]alanine | 4543 | [3H]-alanine | |||||||
[3H]aldosterone | 3452 | [3H]-aldosterone | |||||||
Alexa-488-telenzepine | 8600 | ||||||||
[3H]-almorexant | 9465 | ||||||||
[3H]alniditan | 117 | R-91274 | |||||||
[18F]altanserin | 3242 | [18F]altanserin (PET ligand) | |||||||
[123I]AM251 | 744 | ||||||||
[3H]AMPA | 4077 | ||||||||
[125I]AM (rat) | 3768 | [125I]-adrenomedullin, [125I]-AM | |||||||
[3H]ancriviroc | 802 | [3H]SCH 351125, [3H]Sch-351125 | |||||||
[125I]angiotensin-(1-7) (human, mouse, rat) | 5578 | [125I]ang-(1-7) | |||||||
[125I]ANP (human) | 4845 | [125I]-ANP | |||||||
[125I]antisauvagine | 930 | ||||||||
[3H]AP4 | 1412 | ||||||||
[3H]apafant | 1859 | [3H]WEB 2086 | |||||||
[125I]apelin-13 | 602 | ||||||||
[125I]APNEA | 462 | [3H]N6-2-(4-aminophenyl)ethyladenosine | |||||||
[14C]ascorbic acid | 4532 | [14C]-ascorbic acid | |||||||
[125I]astressin | 924 | ||||||||
[35S]ATPαS | 3407 | [35S]-ATPαS | |||||||
[35S]ATPγS | 5406 | [35S]-ATPgammaS | |||||||
[3H]AVP (human, mouse, rat) | 2175 | [3H]arginine vasopressin | |||||||
[11C]AZ10419369 | 3926 | [11C]AZ10419369 (PET ligand) | |||||||
[3H]AZ11637326 | 3971 | ||||||||
[125I]7-azido-8-iodoketanserine | 4763 | [125I]-7-azido-8-iodoketanserine (photoaffinity ligand), [125I]azidoiodoketanserin, [125I]AZIK | |||||||
[3H]azietomidate | 5404 | ||||||||
B | Back to top | ||||||||
[3H](R)-(-)-baclofen | 3428 | ||||||||
[3H]bag-2 | 8506 | ||||||||
[125I]bantag-1 | 11435 | ||||||||
[3H]banyu (I) | 795 | ||||||||
BAY86-7548 | 11260 | [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2 | |||||||
[125I]BAY 55-9837 | 2281 | ||||||||
[125I]BDNF (human) | 4846 | [125I]-BDNF, [125I]-brain-derived neurotrophic factor | |||||||
[125I]-BDZ2 | 6667 | ||||||||
[125I]BgK (W5Y / Y26F) | 2565 | ||||||||
[125I]BH-AMY (rat, mouse) | 3770 | [125I]-BH-AMY, [125I]-Bolton Hunter amylin | |||||||
[125I]BH-MIT1 | 8522 | ||||||||
[125I]BH-NMB (human, mouse, rat) | 3771 | [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B | |||||||
[125I]BH-[Sar9,Met(O2)11]SP | 3769 | [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P | |||||||
[3H]BH-[Sar9,Met(O2)11]SP | 3811 | [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP | |||||||
[3H]BIBP3226 | 3474 | [3H]-BIBP3226 | |||||||
[125I]BIM23027 | 3772 | [125I]-BIM 23027, [125I]-BIM23027 | |||||||
[3H]BK (human, mouse, rat) | 3812 | [3H]-BK, [3H]-bradykinin | |||||||
BODIPY FL-prazosin | 13134 | QAPB | |||||||
BODIPY-pirenzepine | 8604 | Bodipy[558/568]Pirenzepine, BoPz | |||||||
[125I]BOP | 1973 | [125I]-I-BOP | |||||||
[Bpa6,Tyr10]secretin-27 (rat) | 1154 | ||||||||
[125I]BQ3020 | 1005 | [125I]-BQ3020 | |||||||
[3H]BQ123 | 1003 | [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu | |||||||
[3H]brimonidine (UK14304) | 5386 | [3H]-UK14304 | |||||||
[3H]BSP | 4505 | [3H]-BSP, bromosulfophthalein | |||||||
[125I]α-bungarotoxin | 3972 | ||||||||
[3H]α-bungarotoxin | 3981 | ||||||||
[125I]buserelin | 1167 | [125I]-buserelin | |||||||
[11C]butylthio-TZTP | 3268 | [11C]butylthio-TZTP (PET ligand) | |||||||
[3H]BWA868C | 1899 | ||||||||
C | Back to top | ||||||||
[125I]C3a (human) | 3773 | [125I]-C3a | |||||||
[125I]C5a (human) | 3774 | [125I]-C5a | |||||||
[3H]cAMP | 5096 | [3H]-cAMP | |||||||
[3H]candesartan | 6907 | ||||||||
[125I]cathepsin G (human) | 1017 | [125I]cathepsin G | |||||||
[3H]CCK-8 (human, mouse, rat) | 4765 | [3H]-CCK-8 | |||||||
[125I]CCL11 (human) | 794 | [125I]eotaxin | |||||||
[125I]CCL16 (human) | 1275 | [125I]LEC | |||||||
[125I]CCL17 (human) | 3652 | [125I]TARC | |||||||
[125I]CCL19 (human) | 3655 | [125I]ELC | |||||||
[125I]CCL1 (human) | 814 | [125I]I-309, [125I]P500, [125I]TCA-3 | |||||||
[125I]CCL20 (human) | 3654 | [125I]LARC, [125I]MIP-3α | |||||||
[125I]CCL21 (human) | 3656 | [125I]SLC | |||||||
[125I]CCL25 (human) | 3657 | [125I]TECK | |||||||
[125I]CCL27 (human) | 3653 | [125I]CTACK | |||||||
[125I]CCL2 (human) | 762 | [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1 | |||||||
[125I]CCL3 (human) | 763 | [125I]macrophage inflammatory protein-1α, [125I]MIP-1α | |||||||
[125I]CCL4 (human) | 799 | [125I]macrophage inflammatory protein-1β, [125I]MIP-1β | |||||||
[125I]CCL5 (human) | 764 | [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted | |||||||
[125I]CCL7 (human) | 765 | [125I]MCP-3, [125I]monocyte chemotactic protein-3 | |||||||
[125I]CCL8 (human) | 766 | [125I]MCP-2, [125I]monocyte chemotactic protein-2 | |||||||
[125I]CCL1 (mouse) | 5546 | ||||||||
[3H]CCPA | 379 | [3H]-CCPA | |||||||
[125I]cetrorelix | 1186 | ||||||||
[125I]CGP 23996 | 2022 | ||||||||
[125I]CGP42112 | 594 | [125I]-CGP42112, Cgp 42112B, Cgp-42112A | |||||||
[125I]CGP 64213 | 1076 | [125I]CGP64213 | |||||||
[125I]CGP 71872 | 1077 | [125I]CGP71872, CGP 71872 | |||||||
[3H](-)CGP 12177 | 531 | ||||||||
[3H]CGP12177 | 5387 | [3H]-CGP12177, [3H]CGP 12177 | |||||||
[3H]CGP27492 | 5381 | [3H]-3-APPA, [3H]-CGP27492, [3H]3-APPA | |||||||
[3H]CGP39653 | 4078 | ||||||||
[3H]CGP 54626 | 1090 | [3H]CGP54626 | |||||||
[3H]CGP61594 | 4079 | [3H]CGP 61594 | |||||||
[3H]CGP 62349 | 3429 | [3H]-CGP 62349, [3H]CGP62349 | |||||||
[125I]αCGRP (human) | 3766 | [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP | |||||||
[125I]αCGRP (mouse, rat) | 6567 | ||||||||
[3H]CGS19755 | 4080 | ||||||||
[3H]CGS 21680 | 424 | [3H]-CGS21680 | |||||||
[3H]CGS23131 | 3415 | [3H]CGS 23131, [3H]-CGS23131, LY223982 | |||||||
[3H]CGS8216 | 4366 | ||||||||
chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine | 4770 | ||||||||
[125I]CHIPS | 1027 | [125I]chemotaxis inhibitory protein of S. aureus | |||||||
[125I]chorionic gonadotropin (human) | 3775 | [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin | |||||||
[3H](+)-cis-diltiazem | 2512 | [3H]-(+)-cis-diltiazem | |||||||
[3H]9-cis-retinoic acid | 5383 | [3H]-9-cis-retinoic acid | |||||||
[3H]citalopram | 4621 | [3H]-citalopram | |||||||
[3H]clidinium | 351 | (-)MQNB, [3H](-)N-methyl-3-quinuclidinyl benzilate, Ro-23773 | |||||||
[3H]clonidine | 13162 | ||||||||
[125I]CNP (human) | 4847 | [125I]-CNP | |||||||
[3H]CNQX | 4081 | ||||||||
[125I]α-conotoxin MII | 3975 | ||||||||
[3H]Cp-1 | 9466 | ||||||||
[3H]CP55940 | 734 | ||||||||
[3H]CPP | 4082 | ||||||||
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP | 3921 | [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP | |||||||
[125I]CRF (ovine) | 915 | [125I]corticotropin | |||||||
[3H]5-CT | 262 | [3H]5-carboxamidotryptamine, tritiated 5-carbamidotryptamine | |||||||
[3H]CTEP | 6408 | ||||||||
[125I]CT (human) | 3776 | [125I]-calcitonin (Human), [125I]-CT (Human) | |||||||
[3H]CTOP | 12512 | ||||||||
[125I]CT (salmon) | 3777 | [125I]-calcitonin (Salmon), [125I]-CT (Salmon) | |||||||
[125I]CXCL10 (human) | 3660 | [125I]IP-10 | |||||||
[125I]CXCL11 (human) | 3661 | [125I]I-TAC | |||||||
[125I]CXCL12α (human) | 849 | [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α | |||||||
[125I]CXCL12β (human) | 850 | [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β | |||||||
[125I]CXCL16 (human) | 3662 | ||||||||
[125I]CXCL1 (human) | 3677 | [125I]GROα | |||||||
[125I]CXCL5 (human) | 3659 | [125I]ENA-78 | |||||||
[125I]CXCL7 (human) | 3658 | [125I]NAP-2 | |||||||
[125I]CXCL8 (human) | 822 | [125I]IL-8, [125I]interleukin-8 | |||||||
[125I]CX3CL1 (human) | 3664 | [125I]Fractalkine | |||||||
[125I]CXCL13 (mouse) | 8631 | ||||||||
Cy3B-NMU-8 | 3863 | ||||||||
Cy3B-telenzepine | 8598 | ||||||||
[Cy5-Lys19]NPS | 9166 | Cy5-hNPS | |||||||
[3H]cytisine | 3979 | ||||||||
D | Back to top | ||||||||
[3H][D-Ala2]deltorphin I | 9065 | ||||||||
D-Ala-Lys-AMCA | 5421 | (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid | |||||||
[3H]DAMGO | 3815 | [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO | |||||||
[3H]4-DAMP | 11497 | ||||||||
[3H]darifenacin | 319 | ||||||||
[3H]D-aspartic acid | 4698 | [3H]-D-aspartate, [3H]-D-aspartic acid | |||||||
[35S]dATPαS | 3406 | [35S]-dATPαS | |||||||
[3H]d[Cha4]AVP | 2227 | [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP | |||||||
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP | 2230 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP | 2231 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP | 2232 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | 2233 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | |||||||
[3H]d(CH2)5[Tyr(Me)2]AVP | 3813 | [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP | |||||||
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT | 3778 | [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT | |||||||
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT | 2218 | β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin | |||||||
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT | 2220 | [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA | |||||||
[3H]d[D-Arg8]VP | 5403 | [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP | |||||||
[3H]dDAVP | 2228 | [3H]deamino arginine vasopressin, [3H]desmopressin | |||||||
[3H]dehydroepiandrosterone sulphate | 5577 | [3H]DHEAS, [3H]dehydroepiandrosterone sulfate | |||||||
[3H]deltorphin II | 3816 | [3H]-deltorphin II | |||||||
[3H]2-deoxyglucose | 4643 | 2-deoxy-D-glucose, 2-DG, [3H]-2-deoxyglucose | |||||||
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide | 1166 | ||||||||
[3H]desGly-NH2[D-Ile2,Ile4]VP | 3817 | [3H]-desGly-NH2[D-Ile2,Ile4]AVP | |||||||
[3H](-)devapamil | 2515 | ||||||||
[3H]devazepide | 3476 | [3H]-devazepide | |||||||
[3H]dexamethasone | 3447 | [3H]-dexamethasone | |||||||
[3H]digoxin | 4725 | [3H]-digoxin | |||||||
[3H]dihydroalprenolol | 5388 | [3H]-dihydroalprenolol | |||||||
[3H]dihydrotestosterone | 3455 | [3H]-dihydrotestosterone | |||||||
[3H]dimethyl-W84 | 364 | ||||||||
[3H]-di-o-tolylguanidine | 6685 | [3H]DOTG | |||||||
[3H]diprenorphine | 1612 | [15,16-3H]diprenorphine | |||||||
[125I]DIV880 | 7771 | ||||||||
[3H]dizocilpine | 4089 | [3H]MK-801 | |||||||
[125I]1DMe | 1483 | ||||||||
[3H](+)DOB | 155 | 4-bromo-2,5-dimethoxyphenylisopropylamine, brolamfetamine | |||||||
[125I]DOI | 169 | ||||||||
[111In]DOTA-BOC-ATE | 2063 | [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE | |||||||
[111In]DOTA-dLVT | 3756 | [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT | |||||||
DOTA/Eu relaxin-3 | 11912 | ||||||||
[111In,90Y]DOTA-LAN | 2056 | DOTA-conjugated peptide, YIII-DOTA-LAN | |||||||
[111In]DOTA-NOC | 2045 | [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC | |||||||
[111In,90Y]DOTA-NOC | 2057 | 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC | |||||||
[111In]DOTA-NOC-ATE | 2064 | [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE | |||||||
[111In,90Y]DOTA-OC | 2058 | [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC | |||||||
[111In,90Y]DOTA-TOC | 2059 | YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC | |||||||
[11C]doxepin | 3958 | [11C]-doxepin | |||||||
[3H]DPCPX | 406 | [3H]-DPCPX | |||||||
[3H]DPDPE | 3819 | [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE | |||||||
[11C]DTBZ | 4608 | [11C]-DTBZ , [11C]-DTBZ (PET ligand), dihydrotetrabenazine | |||||||
[125I]α-DTX | 2564 | ||||||||
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) | 631 | [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14) | |||||||
[125I][D-Tyr6]bombesin-(6-13)-methyl ester | 628 | ||||||||
[d-Tyr-14C]TAK-448 | 10223 | ||||||||
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33 | 6666 | ||||||||
E | Back to top | ||||||||
[125I]EGF (human) | 4848 | [125I]-epidermal growth factor | |||||||
[3H]eglumegad | 1396 | [3H]LY354740 | |||||||
[3H]eletriptan | 118 | ||||||||
[3H]EMPA | 9467 | ||||||||
[3H]EM-TBPC | 1390 | ||||||||
[3H]enadoline | 3475 | [3H]-CI977, [3H]-enadoline, [3H]CI-977, [3H]CI977 | |||||||
[125I]epibatidine | 3976 | ||||||||
[3H]epibatidine | 3977 | ||||||||
[3H]eprosartan | 3940 | [3H]-eprosartan, [3H]SK&F 108566 | |||||||
[3H]17β-estradiol | 1012 | [3H]-estradiol, [3H]-estrogen, [3H]E2, [3H]estradiol | |||||||
[3H]estradiol-17β-glucuronide | 4687 | [3H]-estradiol-17β-glucuronide | |||||||
[3H]estrone-3-sulphate | 4748 | [3H]-estrone hydrogen sulfate, [3H]-estrone-3-sulphate, [3H]estrone-3-sulfate | |||||||
[3H]ETB-TBOA | 4492 | [3H]-ETB-TBOA | |||||||
[125I]ET-2 (human) | 992 | [125I]endothelin-2 | |||||||
[125I]ET-1 (human, mouse, rat) | 991 | [125I]endothelin-1 | |||||||
[18F]ET-1 (human, mouse, rat) | 994 | [18F]endothelin-1 | |||||||
Eu-DTPA-hC3a | 11286 | ||||||||
Eu-DTPA-[Ser27, Nle70]hC5a | 12516 | ||||||||
europium-labelled INSL3 | 3875 | ||||||||
europium-labelled INSL5 | 4375 | ||||||||
europium-labelled mouse INSL5 | 6522 | ||||||||
europium-labelled R3(B1-22R) | 8342 | Eu R3(B1-22R) | |||||||
europium-labelled relaxin | 3874 | europium-labelled H2 relaxin | |||||||
europium-labelled relaxin-3-B/INSL5 A chimera | 4374 | Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera | |||||||
[125I]exendin-(9-39) | 1137 | [125I]exendin (9-39) | |||||||
[125I]EXP985 | 3942 | [125I]-EXP985 | |||||||
[125I]EYF | 1488 | [125I]-EYF | |||||||
[3H]EYF | 4021 | [3H]-EYF | |||||||
F | Back to top | ||||||||
[3H]fananserin | 3229 | [3H]RP-62203, [3H]RP62203 | |||||||
[3H]fenobam | 1433 | ||||||||
[18F]FEPPG | 11367 | (S)-N-(2-amino-3-(4-(2-(fluoro-18F)ethoxy)phenyl)propanoyl)-N-methylglycine | |||||||
[18F]FITM | 6213 | ||||||||
florbetaben | 7769 | [18F]BAY 94-9172, AV-1, BAY 94-9172, Neuraceq® | |||||||
florbetapir | 7344 | AMYViD®, AV-45, florbetapir (18F) | |||||||
flortaucipir (18F) | 9100 | 18F-AV-1451, [F-18]T807, flortaucipir F-18, LY-3191748, Tauvid® | |||||||
F2L-[125I]Tyr | 1045 | ||||||||
Flu-CCL3 | 760 | Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α | |||||||
[11C]flumazenil | 4367 | [11C]flumazenil (PET ligand) | |||||||
[3H]flunitrazepam | 4360 | ||||||||
fluorescent MIF ligand B | 9987 | ||||||||
[18F]fluoroethylflumazenil | 4368 | [18F]fluoroethylflumazenil (PET ligand) | |||||||
[3H](+)-fluprostenol | 3417 | [3H]-(+)-fluprostenol | |||||||
flutemetamol | 7342 | 18F-flutemetamol, [18F]flutemetamol, flutemetamol F18 | |||||||
[18F]FMBP | 12670 | ||||||||
[3H]fMet-Leu-Phe | 1018 | [3H]fMet-Leu-Phe, [3H]fMLP | |||||||
fMet-Leu-Phe-Ile-Ile-Lys-FITC | 5843 | ||||||||
[3H]folic acid | 4562 | [3H]-folic acid | |||||||
[3H]folinic acid | 6690 | ||||||||
(3,5)-[19F]2-Phe-ψ-Ala | 11370 | (3,5)-difluoro Phe-ψ-Ala | |||||||
[18F]FPIT | 6392 | ||||||||
[18F]FP-TZTP | 3266 | [18F]FP-TZTP (PET ligand) | |||||||
[125I]FSH (human) | 3780 | [125I]-follicle-stimulating hormone, [125I]-FSH | |||||||
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 | 4050 | Alexa Fluor 594-2fLI | |||||||
[3H]2-furoyl-LIGRL-NH2 | 6660 | ||||||||
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 | 4049 | [3H]propionyl-2fLI | |||||||
G | Back to top | ||||||||
[3H]GABA | 5410 | ||||||||
[3H]gabazine | 4083 | SR95531 | |||||||
[125I]gastrin | 3781 | [125I]-gastrin | |||||||
[3H]gastrin | 3821 | [3H]-gastrin | |||||||
[3H]GBR12935 | 4638 | [3H]-GBR12935 | |||||||
[125I]GDNF (rat) | 4851 | [125I]-GDNF (rat) | |||||||
GE-137 | 8585 | ||||||||
[125I]GHRH (human) | 3783 | [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2 | |||||||
[125I]GIP (human) | 1131 | [125I]-GIP, [125I]gastric inhibitory polypeptide | |||||||
[125I]GLP-1-(7-36)-amide | 1134 | [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36) | |||||||
[125I]GLP-1-(7-37) (human) | 3784 | [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37) | |||||||
[125I][Glp65Nle75,Tyr77]apelin-13 | 3761 | [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13 | |||||||
[125I]glucagon (human, mouse, rat) | 3785 | [125I]-glucagon | |||||||
[14C]glutamine | 4633 | [14C]-glutamine | |||||||
[3H]glutamine | 4634 | [3H]-glutamine | |||||||
[14C]glycine | 4635 | [14C]-glycine | |||||||
[3H]glycine | 4084 | ||||||||
glycyl-[13C3]-sarcosine | 12598 | ||||||||
[11C]GlySar | 4489 | [11C]-GlySar, [11C]glycylsarcosine | |||||||
[14C]GlySar | 4599 | [14C]-GlySar, glycylsarcosine | |||||||
[3H]GlySar | 4659 | [3H]-GlySar, tritiated glycylsarcosine | |||||||
[125I]GnRH I (human, mouse, rat) | 3786 | [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I | |||||||
[125I]GnRH II (human) | 3787 | [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II | |||||||
[125I]GR231118 | 1531 | [125I]1229U91, [125I]GW1229 | |||||||
[3H]GR100679 | 3822 | [3H]-GR100679 | |||||||
[3H]GR 113808 | 259 | GR 125487 [H3], GR113808 | |||||||
[3H]GR 125,743 | 131 | [3H]GR125743, GR125743 | |||||||
[3H]GR65630 | 2303 | [3H]-GR65630 | |||||||
[3H]granisetron | 2292 | [3H]-BRL-43694, [3H]-granisetron | |||||||
[125I]GRP (human) | 3788 | [125I]-gastrin-releasing peptide, [125I]-GRP | |||||||
[11C]GSK215083 | 8430 | ||||||||
[3H]GSK931145 | 4490 | [3H]-GSK931145 | |||||||
[125I]GTI | 3250 | serotonin-5-O-carboxymethyl-glycyl-(125I)tyrosinamide | |||||||
[3H]GW2331 | 2706 | ||||||||
H | Back to top | ||||||||
[3H]haTRAP | 3823 | [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide | |||||||
HEAT (BE2254) | 482 | [125I] BE2254, [125I] HEAT, [125I]-HEAT, [125I]BE2254 | |||||||
[125I]HEAT (BE2254) | 500 | 2-[[2-(4-hydroxy-3-iodanylphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one, 2-{p-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl}-tetralone, [125I]BE-2254, HEAT | |||||||
[3H]HEMADO | 5736 | ||||||||
[3H]hemicholinium-3 | 4493 | [3H]-HC-3 , [3H]-hemicholinium-3, [3H]HC-3 | |||||||
[125I][His9]ghrelin (human) | 1094 | [125I-His9]ghrelin, [125I] His9-ghrelin (human) | |||||||
[3H]histamine | 1247 | ||||||||
[14C]histidine | 4623 | [14C]-histidine | |||||||
[3H]histidine | 4670 | [3H]-histidine | |||||||
[125I]Hpp-desArg10HOE140 | 3791 | [125I]-Hpp-desArg9HOE140 | |||||||
[125I]HPP-HOE140 | 11436 | [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin | |||||||
[125I]-HPP-icatibant | 11158 | [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant | |||||||
[3H]5-HT | 3248 | [3H]-5-HT | |||||||
[3H]HU-243 | 735 | ||||||||
I | Back to top | ||||||||
[35S]ibutamoren | 1097 | [35S]MK-0677 | |||||||
[3H]ICI-198615 | 3414 | [3H]-ICI198615, [3H]ICI-198,615, [3H]ICI198615 | |||||||
ICOA-13 | 11196 | ||||||||
[125I]ICYP | 562 | [125I]cyanopindolol, [125I]iodocyanopindolol | |||||||
[3H]iloprost | 1966 | [3H]-Iloprost, [3H]ciloprost, [3H]ventavis | |||||||
[125I]INSL3 (human) | 1996 | ||||||||
[125I]INSL5 (human) | 2001 | [125I]insulin-like peptide 5 | |||||||
iodipamide | 7400 | adipiodone meglumine, iodipamic acid, radio-cholografin | |||||||
[125I]iodoaminopotentidine | 1230 | [125I]-iodoaminopotentidine, [125I]APT | |||||||
[123I]iodobenzovesamicol | 4762 | [123I]-IBVM, [123I]-iodobenzovesamicol | |||||||
2-iodo-[125I]5MCA-NAT | 5396 | 2-iodo-[125I]-5MCA-NAT | |||||||
[125I]iodophenpropit | 3960 | ||||||||
[123I]iodoproxyfan | 1264 | [125I]-iodoproxyfan | |||||||
[125I](3-iodo-Tyr13)-MCH | 1316 | ||||||||
[125I]iodovinyl-TBZ | 4764 | [125I]-iodovinyl-TBZ , [125I]-iodovinyltetrabenazine | |||||||
[3H]iperoxo | 12486 | ||||||||
[3H]-IPP | 11368 | ||||||||
[3H]irbesartan | 6908 | ||||||||
[125I]IRL1620 | 1007 | [125I]-IRL1620, [125I]IRL 1620 | |||||||
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 | 12493 | ||||||||
[3H](+)-isradipine | 2733 | (+)-[3H]isradipine, (+)-[3H]O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 3H-(+)-PN 200-110 | |||||||
[125I-Tyr]Ac2-26 | 6198 | [125I]ANXA1-derived peptide | |||||||
J | Back to top | ||||||||
[3H]JB-93182 | 908 | ||||||||
[11C]JNJ-16567083 | 3418 | [11C]-JNJ-16567083 | |||||||
[3H]JNJ-40068782 | 6331 | ||||||||
[3H]JNJ 7777120 | 1279 | [3H]-JNJ7777120 | |||||||
K | Back to top | ||||||||
[3H]kainate | 4085 | ||||||||
[125I]KC-Tyr | 832 | ||||||||
[3H]ketanserin | 197 | ||||||||
[125I]kisspeptin-10 (human) | 1281 | [125I]-KP10, [125I]KP-10 | |||||||
[125I]kisspeptin-13 (human) | 3792 | [125I]-kisspeptin13, [125I]-KP13, [125I]KP13 | |||||||
[125I]kisspeptin-14 (human) | 4013 | [125I]KP14 | |||||||
[125I]kisspeptin-54 (human) | 1282 | [125I]KP-54, [125I]metastin | |||||||
L | Back to top | ||||||||
[125I]L703,606 | 3471 | [125I]-L703,606, [125I]L703606 | |||||||
[125I]L750667 | 3295 | [125I]-L750667 | |||||||
[3H]L158809 | 3939 | [3H]-L158809, [3H]L-158,809 | |||||||
[3H]L365260 | 3477 | [3H]L-365,260 | |||||||
[3H]L655708 | 4363 | ||||||||
[3H]L689560 | 4086 | ||||||||
[3H]L748337 | 13196 | ||||||||
[3H]L-aspartic acid | 4534 | [3H]-L-aspartate, [3H]-L-aspartic acid | |||||||
LDV-FITC | 6759 | ||||||||
[3H]Leu-N/OFQ | 3824 | [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ | |||||||
[125I][Leu31,Pro34]NPY | 3762 | [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY | |||||||
[125I]LH | 3793 | [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone | |||||||
[3H]-LKP | 11369 | ||||||||
[3H]losartan | 3941 | [3H]-losartan | |||||||
[3H]LPA | 5395 | [3H]-LPA, [3H]1-oleoyl-LPA, [3H]lysophosphatidic acid | |||||||
[125I]LSD | 261 | [125I]lysergamid, [125I]lysergic acid diethylamide, [125I]lysergide, [125I]N,N-diethyllysergamide | |||||||
[3H]LSD | 219 | [3H]lysergic acid diethylamide, [3H]lysergide, [3H]N,N-diethyllysergamide | |||||||
[3H]LTB4 | 3413 | ||||||||
[3H]LTC4 | 6195 | ||||||||
[3H]LTD4 | 3412 | [3H]-LTD4 | |||||||
[3H]LTE4 | 5863 | ||||||||
[125I]LTT-SRIF-28 | 2023 | 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28 | |||||||
[3H]LXA4 | 3411 | [3H]-LXA4 | |||||||
[3H]LY278584 | 4087 | ||||||||
[3H]LY334370 | 151 | LY334370 | |||||||
[3H]LY341495 | 1399 | [3H]α-9'-xantheylmethyl-2-(carboxycyclopropyl)glycine | |||||||
[3H]Lys-[des-Arg9]BK | 3825 | [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK | |||||||
[3H]Lys-[Leu8][des-Arg9]BK | 3826 | [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK | |||||||
M | Back to top | ||||||||
maltotriose-[125I][Tyr3,Thr8]octreotide | 5631 | [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate | |||||||
[3H]maraviroc | 803 | [3H]UK 427,857, [3H]UK-427,857 | |||||||
[3H]mazindol | 4591 | [3H]-mazindol | |||||||
[125I]MCH (human, mouse, rat) | 1296 | [125I]-melanin-concentrating hormone | |||||||
[3H]MCH (human, mouse, rat) | 3827 | [3H]-MCH, [3H]-melanin-concentraing hormone | |||||||
[3H]MDL105519 | 4088 | ||||||||
MDP-rhodamine | 9506 | MDP-Hex-Rhodamine B | |||||||
[3H]αβ-meATP | 5405 | ||||||||
[3H]meclinertant | 1583 | [3H]-SR48692, [3H]reminertant, [3H]SR-48692 | |||||||
2-[125I]melatonin | 1344 | 2-[125I]MLT, 2-(125I)Iodomelatonin, 2-iodo-[125I]-melatonin, 2[125I]iodomelatonin | |||||||
[3H]melatonin | 1357 | [3H]-melatonin, [3H]MLT | |||||||
[125I][MePhe7]NKB | 3763 | [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB | |||||||
[33P]2MeSADP | 1774 | [33P]2-methylthio-ADP | |||||||
[3H]2MeSADP | 1763 | [3H]2-methylthio-ADP | |||||||
[3H]mesulergine | 232 | ||||||||
[3H]meta-chlorophenylbiguanide | 2304 | ||||||||
[14C]metformin | 4503 | [14C]-metformin | |||||||
[3H]methotrexate | 4674 | [3H]-methotrexate | |||||||
[3H]methoxymethyl-MTEP | 5394 | [3H]-methoxymethyl-MTEP | |||||||
[3H]methoxy-PEPy | 6425 | ||||||||
[14C]methylamine | 4624 | [14C]-methylamine | |||||||
[3H](R)-α-methylhistamine | 1237 | (R)-[3H]α-methylhistamine, [3H]-R-α-Methylhistamine | |||||||
[3H]methyllycaconitine | 3980 | ||||||||
[3H]methyltrienolone | 3457 | [3H]-R1881, [3H]R1881 | |||||||
[3H]MeTRH | 2141 | [3H]Me-thyrotropin-releasing hormone, [3H]pGlu-His(1(τ)-methyl)-ProNH2 | |||||||
[3H]mibolerone | 3456 | ||||||||
[125I]mini-TyrRS | 818 | 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase | |||||||
[3H]mirogabalin | 12597 | ||||||||
[125I]MK-678 | 2061 | ||||||||
[18F]MK-1312 | 6334 | ||||||||
[3H]MK-912 | 527 | [3H]L-657,743 | |||||||
[3H]M-MPEP | 1425 | [3H]-M-MPEP | |||||||
MMP13 tracer [18F]5j | 12669 | ||||||||
[11C]MMTP | 6212 | ||||||||
[125I]motilin (human) | 3794 | [125I]-motilin | |||||||
[3H]MRE 3008F20 | 477 | ||||||||
MRS4174 | 9470 | derivative 30 [PMID: 25299434] | |||||||
MRS4183 | 9471 | compound 11 [PMID: 26303895] | |||||||
[32P]MRS2500 | 1726 | [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate | |||||||
[3H]MRS1754 | 453 | [3H]-MRS1754 | |||||||
[3H]MRS2279 | 1727 | [3H]-MRS2279 | |||||||
MRS4162-BODIPY conjugate | 9469 | BODIPY 630/650 conjugate 28 | |||||||
[14C]MTEP | 1429 | LS-131849 | |||||||
[3H]muscimol | 4090 | ||||||||
Mz438 | 12805 | compound 9a [PMID: 37463496], Mz-438 | |||||||
N | Back to top | ||||||||
[3H]naloxone | 1676 | [N-allyl-2,3-3H]naloxone | |||||||
[3H]naltriben | 3828 | [3H]-naltriben | |||||||
[3H]naltrindole | 3829 | [3H]-naltrindole | |||||||
Nanoluciferase-labelled relaxin | 11464 | ||||||||
NanoLuc-INSL3 | 11913 | ||||||||
NanoLuc R3/I5 chimera | 11465 | ||||||||
[3H]NBI-49202 | 1187 | ||||||||
[125I]N-biotin-[Ahx0, Bpa3]U-II (human) | 9440 | ||||||||
[125I]NDP-MSH | 1326 | [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH | |||||||
[3H]NECA | 425 | [3H]adenosine-5'-(N-ethylcarboxamide) | |||||||
[3H]nelivaptan | 3483 | [3H]-SSR149415, [3H]SSR149415 | |||||||
[3H]nemonapride | 962 | ||||||||
[125I]neuromedin U-25 (human) | 1474 | [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25 | |||||||
[125I]neuromedin U-8 (pig) | 1476 | [125I]NmU-8 (pig), porcine [125I]neuromedin U-8 | |||||||
[125I]neuromedin U-23 (rat) | 1475 | [125I]NmU-23 (rat), rat [125I]neuromedin U-23 | |||||||
[125I]neurotensin (human, mouse, rat) | 1574 | [125I]NT | |||||||
[3H]neurotensin (human, mouse, rat) | 3830 | [3H]-neurotensin | |||||||
[3H]NFPS | 4619 | [3H]-NFPS | |||||||
[3H]NGD941 | 3297 | [3H]-NGD941, [3H]NGD 94-1 | |||||||
[125I]NGF (human) | 4849 | [125I]-nerve growth factor | |||||||
[3H]nicotine | 3978 | ||||||||
[3H]nicotinic acid | 1594 | [3H]-nicotinic acid | |||||||
[3H]nisoxetine | 4636 | [3H]-nisoxetine | |||||||
[3H]nitrobenzylmercaptopurine ribonucleoside | 4511 | [3H]NBMPR, [3H]-NBTI , [3H]NBTI | |||||||
[125I]NKA (human, mouse, rat) | 3795 | [125I]-neurokinin A, [125I]-NKA | |||||||
[125I][Nle75,Tyr77]apelin-36 (human) | 603 | ||||||||
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) | 1791 | ||||||||
[3H]NLX-112 | 3925 | [3H]F13640 | |||||||
[3H]N-methyl-AZ10419369 | 3219 | [N-methyl-3H3]AZ10419369 | |||||||
[3H]N5-methylfolate | 6689 | ||||||||
N-[3H]α-methylhistamine | 1240 | [3H]-Na-methylhistamine, [3H]NAMH | |||||||
N-[3H]methylhistamine | 1241 | ||||||||
[3H]N-methyl scopolamine | 317 | [3H]N-methylscopolamine, [3H]NMS | |||||||
[3H]N-methylspiperone | 196 | [3H]methylspiperone | |||||||
[3H]N-methyl-SSR504734 | 4603 | [3H]-N-methyl-SSR504734 | |||||||
[3H]4NMPB | 352 | [3H](1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate, [3H]1-Methyl-4-piperidyl diphenylglycolate, [3H]enpiperate | |||||||
[67Ga]NODAGA-[Tyr3]octreotide | 5628 | [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC | |||||||
[3H]N/OFQ | 1688 | [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ | |||||||
[35S]non-peptide OT antagonist | 3484 | [35S]-non-peptide OT antagonist | |||||||
[3H]NPC17731 | 3831 | [3H]-NPC17731 | |||||||
[125I]NPFF | 3797 | [125I]-neuropeptide FF, [125I]-NPFF | |||||||
[125I]3-N3-Phpa-LVA | 2206 | ||||||||
[3H](R)-NPTS | 4602 | [3H]-(R)-NPTS | |||||||
[3H]NPVF | 4019 | [3H]-NPVF, [3H]neuropeptide VF | |||||||
[125I]NPW-23 (human) | 1497 | [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW | |||||||
[125I]NPY (human, mouse, rat) | 1518 | [125I]neuropeptide Y | |||||||
[3H]NPY (human, mouse, rat) | 1521 | [3H]neuropeptide Y | |||||||
O | Back to top | ||||||||
[3H]7-OH-DPAT | 3296 | [3H]-7-OH-DPAT | |||||||
[3H]8-OH-DPAT | 31 | ||||||||
[125I]OH-LVA | 2207 | ||||||||
[125I]orexin A (human, mouse, rat) | 3798 | [125I]-orexin A | |||||||
[3H]ORG2058 | 3454 | [3H]-ORG2058 | |||||||
[11C]-ORM-13070 | 13182 | 11C-ORM-13070 | |||||||
[3H]osanetant | 3480 | [3H]SR142,801, [3H]SR142801 | |||||||
[3H]OSIP339391 | 454 | ||||||||
[3H]OT (human, mouse, rat) | 2176 | [3H]oxytocin | |||||||
[3H]5-oxo-ETE | 3416 | [3H]-5-oxo-ETE | |||||||
[3H]oxotremorine-M | 8595 | ||||||||
P | Back to top | ||||||||
[125I]PACAP-27 | 2261 | [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27 | |||||||
[3H]PAF | 1833 | [3H]platelet activating factor | |||||||
[3H]paroxetine | 4561 | [3H]-paroxetine | |||||||
[3H]PBC-264 | 899 | [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264 | |||||||
[125I]PD142308 | 3472 | ||||||||
[125I]PD151242 | 1001 | [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242 | |||||||
[125I]PD164333 | 1002 | [125I]-PD164333 | |||||||
[3H]PD128907 | 3298 | [3H]PD 128907, [3H]-PD128907 | |||||||
[3H]PD140376 | 3478 | [3H]-PD140,376, [3H]PD 140376 | |||||||
[3H]pemetrexed | 6688 | ||||||||
[3H]pentazocine | 6683 | ||||||||
[18F]PF-06684511 | 9832 | ||||||||
[3H]PGD2 | 1891 | [3H]-PGD2, [3H]11-dehydroprostaglandin F2-alpha, [3H]prostaglandin D2 | |||||||
[3H]PGE2 | 1916 | [3H]-PGE2, [3H]prostaglandin E2, [3H]prostin E2 | |||||||
[3H]PGF2α | 1957 | [3H]dinoprost, [3H]prostaglandin F2alpha | |||||||
[125I][Phe13,Tyr19]MCH | 3844 | [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone | |||||||
[125I]p-iodoclonidine | 13179 | [125I]p-iodo-Clonidine | |||||||
[3H]pirenzepine | 3272 | [3H]PZ | |||||||
[3H]PL017 | 3832 | [3H]-PL017 | |||||||
p-[18F]MPPF | 3227 | [(18)F]p-MPPF, P-[18F]MPPF | |||||||
[3H]p-MPPF | 81 | ||||||||
[125I][PP1-17,Ala31,Aib32]NPY (human) | 1559 | ||||||||
[125I]PP (human) | 3800 | [125I]-pancreatic polypeptide, [125I]-PP | |||||||
[3H]prazosin | 5385 | [3H]-prazosin | |||||||
[3H]pregnenolone sulphate | 6504 | [3H]-pregnenolone sulfate | |||||||
[125I]PrRP31 | 4022 | [125I]-PrRP31 | |||||||
[125I]PrRP-20 (human) | 1875 | [125I]prolactin-releasing peptide-20 | |||||||
[125I]psalmotoxin 1 | 4073 | [125I]-PcTx1 | |||||||
[3H]PSB-0413 | 6147 | [3H]AR-C67085, [3H]AR-C67085MX | |||||||
[3H]PSB-11 | 5729 | ||||||||
[3H]PSB603 | 5728 | ||||||||
[125I]PTA-OH | 1981 | I-PTA-OH | |||||||
[125I](Pyr1)apelin-13 | 601 | ||||||||
[11C]pyrilamine | 3957 | [11C]-mepyramine, [11C]-pyrilamine | |||||||
[3H]pyrilamine | 1220 | [3H]mepyramine | |||||||
[3H](Pyr1)[Met(0)11]-apelin-13 | 604 | ||||||||
[125I]PYY | 1519 | [125I]peptide tyrosine tyrosine, [125I]peptide YY | |||||||
[125I]PYY-(3-36) (human) | 3802 | [125I]-peptide YY(3-36), [125I]-PYY(3-36) | |||||||
[125I]PYY (pig) | 1520 | [125I]pPYY | |||||||
Q | Back to top | ||||||||
[3H]QNB | 318 | [3H]quinuclidinylbenzilate | |||||||
[125I]QRFP43 (human) | 3803 | [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP | |||||||
[3H]quisqualate | 1370 | ||||||||
R | Back to top | ||||||||
[3H]R214127 | 1391 | [3H]-R214127 | |||||||
[3H]raclopride | 3299 | [3H]-raclopride | |||||||
[3H]ramatroban | 1910 | [3H]Bay u 3405, [3H]BAY u3405, [3H]baynas | |||||||
[3H]ramosetron | 2305 | ||||||||
[3H]rauwolscine | 223 | ||||||||
[125I]relaxin-3-B/INSL5 A chimera | 3789 | [125I]H3-B/INSL5 A chimera | |||||||
[125I]relaxin-3 (human) | 1999 | [125I]H3-relaxin (human) | |||||||
[125I]relaxin (human) | 5398 | [125I]H2 relaxin | |||||||
[33P]relaxin (human) | 1991 | [33P]H2 relaxin (human), [33P]Human gene 2 relaxin | |||||||
[3H]relcovaptan | 3482 | [3H] SR 49059, [3H]SR-49059, [3H]SR49059 | |||||||
[125I]resiniferatoxin | 2492 | ||||||||
[3H]resiniferatoxin | 4091 | ||||||||
[3H]resolvin D1 | 4356 | [3H]-RvD1 | |||||||
[3H]resolvin E1 | 2901 | [(3)H]-labeled RvE1, [3H]RvE1 | |||||||
[125I]26RFa (human) | 10253 | ||||||||
[3H]rimonabant | 745 | [3H]-rimonabant, [3H]-SR141716, [3H]SR141716A | |||||||
R3/I5- SmBiT | 11911 | ||||||||
[3H]Ro154513 | 4365 | ||||||||
[3H]Ro 63-0563 | 3246 | ||||||||
[3H]robalzotan | 82 | [3H]NAD 299, [3H]NAD-299 | |||||||
[3H]rolipram | 5313 | [3H]-rolipram | |||||||
[3H]52770 RP | 1858 | ||||||||
[18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate | 3275 | (R,R)-[18F]-FMeQNB, (R,R)-quinuclidinyl-4-[18F]-fluoromethyl-benzilate, (R,R)-quinuclidinyl-4-[18F]-fluoromethylbenzilate(PET ligand), [18F]-FMeQNB | |||||||
[3H]RS 57639 | 239 | RS57639 | |||||||
[125I]RTI55 | 5409 | [125I]-RTI55, [3H]β-CIT, [3H]iometopane | |||||||
[3H]RX821002 | 528 | [3H]2-methoxyidazoxan | |||||||
[3H]RY80 | 4364 | ||||||||
S | Back to top | ||||||||
[125I]S36057 | 1317 | ||||||||
[125I]S70254 | 7779 | ||||||||
[3H]S0139 | 3479 | [3H]-S0139, [3H]S-0139 | |||||||
[3H]S-145 | 1984 | ||||||||
[3H]S-15535 | 32 | ||||||||
[125I]SAP | 1982 | [125I]-SAP, I-SAP, Isap acid | |||||||
[125I]sarafotoxin S6b | 993 | ||||||||
[125I][Sar1]Ang-II | 6897 | ||||||||
[125I][Sar1, D-Ala8]Ang II | 12299 | 125I-Sarcosine1, D-Alanine8-Angiotensin II | |||||||
[3H]saredutant | 3481 | [3H]-SR49868, [3H]SR48,968, [3H]SR48968 | |||||||
[125I][Sar1,Ile8]Ang-II | 6906 | ||||||||
[125I]sauvagine (frog) | 916 | ||||||||
[11C]SB207145 | 3244 | [11C] SB207145 (PET ligand) | |||||||
[123I]SB 207710 | 3243 | ||||||||
[125I]SB-236636 | 2710 | ||||||||
[125I]SB258585 | 3245 | ||||||||
[3H]SB269970 | 3247 | ||||||||
[3H]SB-674042 | 1706 | ||||||||
[3H]SB-733993 | 4491 | [3H]-(2R)-3-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-2-hydroxy-S-(naphthalen-1-yl)propane-1-sulfonamido , [3H]-SB-733993 | |||||||
[125I]SCH23982 | 945 | [125I]-SCH23982 | |||||||
[3H]SCH-23390 | 946 | [3H]-SCH23390 | |||||||
[3H]SCH 58261 | 431 | ||||||||
[125I]SD6 | 7770 | ||||||||
[125I]secretin (pig) | 1153 | ||||||||
[3H]senktide | 3834 | [3H]-senktide | |||||||
12S-[3H]HETE | 5508 | ||||||||
[125I]SHU9119 | 3804 | [125I]-SHU9119 | |||||||
[3H]SNAP-7941 | 1318 | ||||||||
[32P]S1P | 5402 | [32P]-S1P | |||||||
[18F]SPA-RQ | 3473 | [18F]-SPA-RQ | |||||||
[125I]spexin-1 | 11418 | ||||||||
[125I]SP (human, mouse, rat) | 3805 | [125I]-SP, [125I]-substance P | |||||||
[3H]SP (human, mouse, rat) | 3835 | [3H]-SP, [3H]-substance P | |||||||
[3H]spiperone | 3300 | [3H]-spiperone | |||||||
[125I]SQ-29548 | 1983 | ||||||||
[3H]SQ-29548 | 1985 | [3H]-SQ29548, [3H]SQ-28053, [3H]SQ29548 | |||||||
[3H]SR 121463A | 2234 | [3H]-SR121463A | |||||||
[125I]Sta | 4850 | [125I]-Sta | |||||||
[3H]strychnine | 2360 | ||||||||
[3H]sumatriptan | 119 | ||||||||
[3H]SYM2081 | 4075 | [(3)H]4MG, [3H](2S,4R)-4-methylglutamate | |||||||
T | Back to top | ||||||||
[3H]T-516 | 11449 | ||||||||
[3H]tamoxifen | 5384 | [3H]-tamoxifen | |||||||
TamRLX | 11462 | ||||||||
[3H]taurocholic acid | 4546 | [3H]-taurocholate , [3H]-taurocholic acid | |||||||
[35S]TBPS | 4369 | ||||||||
[3H]TBZOH | 4766 | α-[O-methyl-3H]dihydrotetrabenazine, [3H]-TBZOH , [3H]dihydrotetrabenazine | |||||||
[3H]-TCS 1102 | 11527 | [3H]-BBAC, [3H]-compound 18 | |||||||
[14C]TEA | 4575 | [14C]-TEA , tetraethylammonium | |||||||
[3H](+)telenzepine | 8594 | ||||||||
[3H]2,2,2-TEMPS | 6328 | [3H]-PAM | |||||||
[125I]tertiapin Y1/K12/Q13 | 2382 | ||||||||
[3H]thiamine | 4628 | [3H]-thiamine, [3H]vitamin B1 | |||||||
[125I]thyroxine | 4627 | [125I]-T4, [125I]-thyroxine | |||||||
[3H]tiagabine | 4685 | ||||||||
[3H]tiotidine | 3959 | [3H]-tiotidine | |||||||
[3H]tiotropium | 8592 | ||||||||
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 | 3914 | ||||||||
[3H]TRH (human, mouse, rat) | 3836 | [3H]-thyrotropin-releasing hormone, [3H]-TRH | |||||||
[125I]triptorelin | 1168 | [125I][D-Trp6]GnRH | |||||||
[125I]TSH (human) | 3806 | [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH | |||||||
[125I]Tyr-Ala-hexarelin | 1095 | ||||||||
[3H]tyramine | 2148 | [3H]-Tyramine | |||||||
[125I][Tyr4]bombesin | 623 | [125I-Tyr4]BN | |||||||
[125I][Tyr8]bradykinin | 3765 | [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK | |||||||
[125I]Tyr0-CRF (human, rat, mouse) | 914 | [125I]-Tyr0-corticotropin | |||||||
[125I]Tyr10-CST14 | 2024 | [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14 | |||||||
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH | 1165 | ||||||||
[125I][Tyr11]des-Br-NPB-23 | 1498 | [125I][Tyr11]des-Br-neuropeptide B-23 | |||||||
[125I]Tyr4-des-octanoyl-ghrelin | 3810 | [125I]-Tyr4-des-octanoyl-ghrelin | |||||||
[125I][Tyr26]galanin (human) | 5391 | [125I]-[Tyr26]galanin | |||||||
[125I][Tyr26]galanin (pig) | 6117 | ||||||||
[125I][Tyr26]galanin (rat/mouse) | 5390 | [125I]-[Tyr26]galanin | |||||||
[125I][Tyr4]ghrelin (human) | 1096 | [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin | |||||||
[125I]Tyr45-kisspeptin-15 | 1280 | [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15 | |||||||
[3H]Tyr14-N/OFQ | 1687 | [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ | |||||||
[125I]Tyr10NPS (human) | 1493 | human [125I]Tyr10-neuropeptide S | |||||||
[125I]Tyr0-sauvagine | 5389 | [125I]-Tyr0-sauvagine | |||||||
[125I](Tyr10)secretin-27 (rat) | 3759 | [125I]-(Tyr10)secretin | |||||||
[125I]Tyr3 SMS 201-995 | 2062 | [125I][Tyr3]octreotide | |||||||
[125I]Tyr11-SRIF-14 | 2060 | [125I]Tyr11-SS-14 | |||||||
[125I]Tyr7-Sst3-ODN-8 | 2075 | ||||||||
[125I][Tyr3,Thr8]octreotide | 5630 | [125I]-TOCA, [125I]-Tyr3-octreotate | |||||||
U | Back to top | ||||||||
[3H]U46619 | 1974 | [3H]U 46619 | |||||||
[3H]U69593 | 1656 | [3H]-U69593 | |||||||
[3H]UBP310 | 4092 | ||||||||
[125I]U-II (human) | 2158 | human [125I-Tyr9] urotensin-II, human [125I] urotensin-II | |||||||
[125I]urocortin 1 (mouse, rat) | 917 | ||||||||
V | Back to top | ||||||||
[3H]valsartan | 593 | ||||||||
[3H]vesamicol | 4758 | [3H]-vesamicol | |||||||
[125I]VIP (human, mouse, rat) | 2277 | [125I]-VIP, [125I]vasoactive intestinal peptide | |||||||
[11C]volinanserin | 3249 | [11C]M100907 (PET ligand), [11C]MDL100907 | |||||||
W | Back to top | ||||||||
[11C]WAY100635 | 3252 | [11C]WAY-100635, [11C]WAY100635 (PET ligand) | |||||||
[3H]WAY100635 | 3251 | ||||||||
[3H]WIN35428 | 4605 | [3H]-β-CFT, [3H]-2β-carboxymethy-3β-(4-fluorophenyl)tropane , [3H]-WIN35428 | |||||||
[3H]WIN55212-2 | 736 | ||||||||
X | Back to top | ||||||||
[3H]XAC | 432 | [3H]xanthine amine congener | |||||||
[11C]xanomeline | 3278 | [11C]xanomeline (PET ligand) | |||||||
[125I]XCL1 (human) | 857 | [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α | |||||||
Y | Back to top | ||||||||
[3H]YM298198 | 5392 | [3H]-YM298198 | |||||||
[125I]Y-RFRP-3 | 1484 | [125I]YVP | |||||||
yttrium (90Y) clivatuzumab tetraxetan | 8087 | 90Y-hPAM4, hPAM4, hPAM4-Cide, IMMU-107 | |||||||
Z | Back to top | ||||||||
[3H](S)-zacopride | 4074 | ||||||||
[125I]ZM-241385 | 430 | ||||||||
[3H]ZM 241385 | 455 | [3H]-ZM241385 | |||||||
[3H]zolpidem | 4362 | ||||||||